Comparing The Efficacy Of Metacognitive Group Therapy And Cognitive - Behavioral GroupTherapy On Reducing Of The Symptoms And Metacognitive Factors Of Social Anxiety Disorder In Students.

Comparing The Efficacy Of Metacognitive Group Therapy And Cognitive - Behavioral GroupTherapy On Reducing Of The Symptoms And Metacognitive Factors Of Social Anxiety Disorder In Students:Double Blind Randomized Clinical Trial.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190518043626N1

Enrollment

Registered

2019-05-23

Start date

2019-06-01

Completion date

Unknown

Last updated

2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

social anxiety disorder. Social phobias

Interventions

Intervention 1: Intervention group:Cognitive-behavioral group therapy Based on Hoffman model. Intervention 2: Intervention group:Metacognitive group therapy. Intervention 3: Control group:No intervent

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Tendency to participate in research. A score of between 21 and 40 (mild to moderate social anxiety) in SPIN. Age of 18 years and older. Residence in Zanjan city during research. Being a student.

Exclusion criteria

Exclusion criteria: At the same time receive psychological treatment. Absence of more than two continuous sessions in therapeutic sessions. Lack of participation in one of the three stages of evaluation. History of psychosis, alcohol related disorders, bipolar disorder and personality disorders. At the same time taking psychiatric medications. Score 15 to 25 in BDI-II.

Design outcomes

Primary

Measure	Time frame
Symptoms of Social Anxiety Disorder. Timepoint: Pre-test, post-test and follow-up (three months after the post-test). Method of measurement: Conver social phobia Questionnaire(SPIN) and social interaction anxiety scale(SIAS).;Social phobia. Timepoint: Pre-test, post-test and follow-up (three months after the post-test). Method of measurement: Conver social phobia Questionnaire(SPIN).;Social interaction. Timepoint: Pre-test, post-test and follow-up (three months after the post-test). Method of measurement: social interaction anxiety scale(SIAS).;Fear of negative evaluation. Timepoint: Pre-test, post-test and follow-up (three months after the post-test). Method of measurement: Fear of negative evaluation of short form questionnaire(FNES-B).;Cognitive-attentional syndrome. Timepoint: Pre-test, post-test and follow-up (three months after the post-test). Method of measurement: CAS-1.;Negative metacognitive beliefs about risk and uncontrollability. Timepoint: Pre-test, post-test and follow-up (three months after the post-test). Method of measurement: MCQ-30.;Positive metacognitive beliefs about worries. Timepoint: Pre-test, post-test and follow-up (three months after the post-test). Method of measurement: MCQ-30.;Cognitive Confidence. Timepoint: Pre-test, post-test and follow-up (three months after the post-test). Method of measurement: MCQ-30.;Cognitive self-awareness. Timepoint: Pre-test, post-test and follow-up (three months after the post-test). Method of measurement: MCQ-30.;Need to control thought. Timepoint: Pre-test, post-test and follow-up (three months after the post-test). Method of measurement: MCQ-30.	—

Measure

Time frame

Symptoms of Social Anxiety Disorder. Timepoint: Pre-test, post-test and follow-up (three months after the post-test). Method of measurement: Conver social phobia Questionnaire(SPIN) and social interaction anxiety scale(SIAS).;Social phobia. Timepoint: Pre-test, post-test and follow-up (three months after the post-test). Method of measurement: Conver social phobia Questionnaire(SPIN).;Social interaction. Timepoint: Pre-test, post-test and follow-up (three months after the post-test). Method of measurement: social interaction anxiety scale(SIAS).;Fear of negative evaluation. Timepoint: Pre-test, post-test and follow-up (three months after the post-test). Method of measurement: Fear of negative evaluation of short form questionnaire(FNES-B).;Cognitive-attentional syndrome. Timepoint: Pre-test, post-test and follow-up (three months after the post-test). Method of measurement: CAS-1.;Negative metacognitive beliefs about risk and uncontrollability. Timepoint: Pre-test, post-test and follow-up (three months after the post-test). Method of measurement: MCQ-30.;Positive metacognitive beliefs about worries. Timepoint: Pre-test, post-test and follow-up (three months after the post-test). Method of measurement: MCQ-30.;Cognitive Confidence. Timepoint: Pre-test, post-test and follow-up (three months after the post-test). Method of measurement: MCQ-30.;Cognitive self-awareness. Timepoint: Pre-test, post-test and follow-up (three months after the post-test). Method of measurement: MCQ-30.;Need to control thought. Timepoint: Pre-test, post-test and follow-up (three months after the post-test). Method of measurement: MCQ-30.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaeedeh Zenoozian

Zanjan University of Medical Sciences

Zenoozian@zums.ac.ir+98 24 3354 2403

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026